Building No. 1
4-5th Floor 16 North Hongda Road Beijing Economic-Technological Dev. Area
Beijing
China
https://www.acotec.cn
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 638
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Ms. Jing Li | Executive Chairperson of the Board & CEO | 4,06M | N/A | 1973 |
Mr. Silvio Rudolf Schaffner | COO & Executive Director | 2,48M | N/A | 1970 |
Dr. Ulrich Reinhold Speck | Chief Technology Officer | N/A | N/A | 1942 |
Mr. Chen Li | Joint Company Secretary | N/A | N/A | 1990 |
Ms. Ching Yi Li | Joint Company Secretary | N/A | N/A | N/A |
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China, Europe, and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery (SFA) and popliteal artery (PPA) for the treatment of lower extremity artery disease (LEAD) with a vascular interventional approach; and AcoArt Tulip & Litos, a paclitaxel coated DCB used to prevent stenosis or occlusion in below-theknee (BTK) arteries for the treatment of chronic limb-threatening ischemia with a vascular interventional approach. It also offers devices targeting vascular surgery, including AcoArt Iris & Jasmin; AcoArt Lily & Rosmarin; Peripheral Aspiration System (AcoStream); Radiofrequency Ablation System (AcoArt Cedar); Peripheral Support Catheter (Vericor); The PTA Balloon (P-Conic); and 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream). In addition, its devices targeting cardiology include Semi-compliant PTCA Balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), and Coronary CTO Antegrade Micro-Catheter (Vericor-14); devices targeting nephrology include Paclitaxel Coated High-Pressure Balloon (ACOART AVENS) and AV Scoring Balloon (Peridge); devices targeting neurology comprise Intracranial PTA Balloon (NEO-Skater); and devices targeting andrology include AcoArt Orchid & Dhalia and AcoArt Tulip & Litos. Further, the company trades procedural medical devices. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited operates as a subsidiary of Boston Scientific Group plc.
El ISS Governance QualityScore de Acotec Scientific Holdings Limited, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.